View the latest BioMarin Pharmaceutical Inc. (BMRN) stock price, news, historical charts, analyst ratings and financial information from WSJ. BioMarin Pharmaceutical stock Target Raised by SunTrust Banks, Inc. on 6/18/2020. In a note to investors, the firm issued a new target price of $143.00. March 12th, 2020 - Motley Fool BioMarin's stock isn't escaping the marketwide sell-off. BioMarin proudly named to Forbes magazine's 2019 Best Midsize Employers list – a ranking of companies liked best by employees; The list has BioMarin ranked #4 in America and #1 in the “Drug & Biotechnology Industry"

During Monday’s Afternoon trade, Shares of Bio Marin Pharmaceutical Inc. (NASDAQ:BMRN), gained 0.47% to $97.46.. BioMarin Pharmaceutical Inc. (BMRN), declared data analysis for Kyndrisa demonstrating compriseent evidence of efficacy in comparable patients across three randomized, placebo-controlled studies that were conducted contemporaneously. BioMarin Pharmaceutical stock has undergone multiple analysts rating changes in the recent past. NASDAQ:BMRN laying on the strong support line near $87.87 and can move up suddenly. Why BioMarin Pharmaceutical Inc. Stock Is Fading Today BioMarin's stock isn't escaping the marketwide sell-off. Dive deeper with interactive charts and top stories of BIOMARIN PHARMACEUTICAL INC.. View daily, weekly or monthly format back to when BioMarin Pharmaceutical Inc. stock was issued. The high price target for BMRN is $150.00 and the low price target for BMRN is $77.00. BioMarin Pharmaceutical's stock is owned by many different retail and institutional investors. Over the last 12 months, BMRN stock rose by 30.18%. BioMarin Pharmaceutical (BMRN), Mondelez International (MDLZ) and Twilio (TWLO) are all teetering on the brink of bearish signals. BioMarin Pharmaceuticals (NASDAQ: BMRN) has not escaped the market sell-off caused by the COVID-19 pandemic. BioMarin Pharmaceutical Inc. [NASDAQ: BMRN] stock went on an upward path that rose over 4.56% on Wednesday, amounting to a one-week price increase of more than 3.40%. The … BMRN: Get the latest Biomarin Pharmaceutical stock price and detailed information including BMRN news, historical charts and realtime prices. BioMarin Pharmaceutical Inc. Common Stock (BMRN) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. See today’s analyst top recommended stocks >> Tivity Health (TVTY) Stock analysis for BioMarin Pharmaceutical Inc (BMRN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

View real-time stock prices and stock quotes for a full financial overview.

BMRN | Complete BioMarin Pharmaceutical Inc. stock news by MarketWatch. The one-year BioMarin Pharmaceutical Inc. stock forecast points to a potential upside of 7.73.

On the stock market today, BioMarin stock dipped 2% to close at 87.61.In earlier trading, BioMarin shares fell as much as 6%.